{
    "thread": {
        "uuid": "c4c11bf577c4254a3ab8d2f033770746212fab94",
        "url": "https://mx.advfn.com/bolsa-de-valores/noticias/92972097/pharmaceutical-contract-manufacturing-market-to-gr",
        "site_full": "mx.advfn.com",
        "site": "advfn.com",
        "site_section": "https://mx.advfn.com/",
        "site_categories": [],
        "section_title": "ADVFN - Criptodivisas, forex y precios del mercado burs&aacute;til mundial.",
        "title": "Pharmaceutical Contract Manufacturing Market to grow by USD 58 billion from 2022 to 2027, North America to account for 41% of market growth - Technavio",
        "title_full": "Pharmaceutical Contract Manufacturing Market to grow by USD 58 billion from 2022 to 2027, North America to account for 41% of market growth - Technavio",
        "published": "2024-01-05T18:35:00.000+02:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "GB",
        "main_image": "",
        "performance_score": 0,
        "domain_rank": 8826,
        "domain_rank_updated": "2024-01-02T12:06:49.000+02:00",
        "reach": null,
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "gplus": {
                "shares": 0
            },
            "pinterest": {
                "shares": 0
            },
            "linkedin": {
                "shares": 0
            },
            "stumbledupon": {
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "c4c11bf577c4254a3ab8d2f033770746212fab94",
    "url": "https://mx.advfn.com/bolsa-de-valores/noticias/92972097/pharmaceutical-contract-manufacturing-market-to-gr",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "PR Newswire (US)",
    "published": "2024-01-05T18:35:00.000+02:00",
    "title": "Pharmaceutical Contract Manufacturing Market to grow by USD 58 billion from 2022 to 2027, North America to account for 41% of market growth - Technavio",
    "text": "NEW YORK , Jan. 5, 2024 /PRNewswire/ -- The pharmaceutical contract manufacturing market is expected to grow by USD 58 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 7.81% during the forecast period, according to Technavio Research. The market is segmented by end-user (big pharmaceutical companies, small and medium-sized pharmaceutical companies, and generic pharmaceutical companies), service (API/bulk drug manufacturing, final dosage form, and secondary packaging), and geography ( North America , Asia , Europe , and Rest of World (ROW)). North America is estimated to contribute 41% to the growth of the global market during the forecast period. Increasing demand for effective and cost-effective solutions in the production of pharmaceutical products is driving growth. Often these medicines are specially formulated and require special production methods that do not exist in-house for drug companies.\nThis report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a Free PDF Sample Report\nCompany Profile:\nAbbVie Inc., Almac Group Ltd., Baxter International Inc., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd., Dalton Pharma Services, Dr Reddys Laboratories Ltd., Grifols SA, Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, OPTIMAPHARM d.o.o., Parexel International Corp., PCI Pharma Services, Recipharm AB, Syneos Health Inc., and Thermo Fisher Scientific Inc.\nAlmac Group Ltd. - The company offers pharmaceutical contract manufacturing services such as diagnostic services, API services, and pharmaceutical development.\nTo gain access to more company profiles available with Technavio, buy the report!\nPharmaceutical Contract Manufacturing Market: Segmentation Analysis The market share growth by the big pharmaceutical companies segment will be significant during the forecast period. The efforts of the big pharmaceutical companies have also been prioritized for their core competencies.\nLearn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a Free PDF Sample Report\nPharmaceutical Contract Manufacturing Market: Driver & Trend:\nKey Driver\nPatent expiry and increasing demand for generic drugs Growing need to focus on core competencies Strong research funding T he patent expiry and increasing demand for generic drugs is the key factor driving market growth. Generic medicines are less expensive than the branded version and have comparable therapeutic safety and efficacy. Another major reason for the expansion of the Generic Medicines Industry is the expiry of various patents on medicinal products. In emerging nations\nMajor Trend\nThe increase in US FDA-approved manufacturing facilities in emerging markets is a key trend in the market. Identify key trends, drivers, and challenges in the market. Download a sample to gain access to this information.\nRelated Reports:\nThe pharmaceutical continuous manufacturing market size is estimated to grow by USD 548.94 million at a CAGR of 12.74% between 2023 and 2028.\nThe In Vitro Diagnostics (IVD) Contract Manufacturing Market size is estimated to grow by USD 9,370.27 million at a CAGR of 11.84% between 2022 and 2027.\nWhat are the key data covered in this pharmaceutical contract manufacturing market report?\nCAGR of the market during the forecast period Detailed information on factors that will drive the growth of the pharmaceutical contract manufacturing market between 2022 and 2027. Precise estimation of the pharmaceutical contract manufacturing market size and its contribution to the market in focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the pharmaceutical contract manufacturing market across North America, Europe, Asia, and ROW A thorough analysis of the market's competitive landscape and detailed information about companies Comprehensive analysis of factors that will challenge the growth of pharmaceutical contract manufacturing market companies. ToC:\nExecutive Summary\nMarket Landscape\nMarket Sizing\nHistoric Market Sizes\nFive Forces Analysis\nMarket Segmentation by End-User\nMarket Segmentation by Service\nMarket Segmentation by Geography\nCustomer Landscape\nGeographic Landscape\nDrivers, Challenges, & Trends\nCompany Landscape\nCompany Analysis\nAppendix\nAbout Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.\nWith over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.\nContacts\nTechnavio Research\nJesse Maida\nMedia & Marketing Executive\nUS: +1 844 364 1100\nUK: +44 203 893 3200\nEmail: media@technavio.com\nWebsite: www.technavio.com\nView original content to download multimedia:https://www.prnewswire.com/news-releases/pharmaceutical-contract-manufacturing-market-to-grow-by-usd-58-billion-from-2022-to-2027-north-america-to-account-for-41-of-market-growth---technavio-302026185.html\nSOURCE Technavio\nCopyright 2024 PR Newswire",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
        "Science and Technology",
        "Economy, Business and Finance",
        "Health"
    ],
    "external_links": [
        "https://www.prnewswire.com/news-releases/pharmaceutical-contract-manufacturing-market-to-grow-by-usd-58-billion-from-2022-to-2027-north-america-to-account-for-41-of-market-growth---technavio-302026185.html",
        "https://prnewswire.com/news-releases/pharmaceutical-contract-manufacturing-market-to-grow-by-usd-58-billion-from-2022-to-2027-north-america-to-account-for-41-of-market-growth---technavio-302026185.html"
    ],
    "external_images": [],
    "entities": {
        "persons": [],
        "organizations": [
            {
                "name": "technavio research",
                "sentiment": "none"
            }
        ],
        "locations": [
            {
                "name": "new york",
                "sentiment": "none"
            },
            {
                "name": "north america",
                "sentiment": "none"
            },
            {
                "name": "asia",
                "sentiment": "none"
            },
            {
                "name": "europe",
                "sentiment": "none"
            }
        ]
    },
    "rating": null,
    "crawled": "2024-01-06T00:53:34.243+02:00",
    "updated": "2024-01-06T00:53:34.243+02:00"
}